SK Capital’s investment will serve as a catalyst for a new strategic direction as the Company seeks to deepen and expand its presence in fine chemistries for the global life science market.
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
99% of Pristyn Doctors are using EMR facility on its doctor app
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
New deal strengthens Congenica’s presence in India
Investment in response to increased demand for North American-based chemistry services
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
Subscribe To Our Newsletter & Stay Updated
